The Association between Long Non-Coding RNAs and Alzheimer's Disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neurodegeneration, common in aging, is exacerbated by pathological mechanisms, notably in Alzheimer's disease (AD).
• Current AD therapeutics are largely ineffective, highlighting gaps in understanding disease mechanisms.
• Long non-coding RNAs (lncRNAs) are regulatory RNA molecules implicated in various cellular processes and diseases, including neurodegenerative disorders.

Purpose of the Study:

• To provide a comprehensive overview of the current knowledge on lncRNAs in AD.
• To discuss the potential of lncRNAs as diagnostic biomarkers and therapeutic targets for AD.
• To highlight the need for further research into gender-associated lncRNA expression in AD.

Main Methods:

• Literature review of studies on lncRNAs and neurodegenerative diseases, with a focus on AD.
• Analysis of the regulatory roles and expression patterns of lncRNAs in pathological conditions.
• Examination of gender-specific alterations in lncRNA expression in AD.

Main Results:

• Dysregulation of specific lncRNAs is associated with neurodegeneration and AD progression.
• lncRNAs exhibit potential as biomarkers for early diagnosis and as targets for novel RNA therapeutics.
• Altered lncRNA expression in AD shows a gender-dependent pattern, suggesting biological sex influences disease mechanisms.

Conclusions:

• lncRNAs represent a promising area for AD research, offering potential for both diagnostic and therapeutic advancements.
• Understanding the complex roles of lncRNAs, including sex-specific effects, is critical for developing effective AD interventions.
• The rapid growth in lncRNA research and the development of RNA therapeutics indicate a significant future for this field in combating neurodegenerative diseases like AD.